Max Darnell ^UDM

Max Darnell, Co-founder and CEO at Modulus Therapeutics, is dedicated to helping patients live longer, healthier lives by discovering next-generation cell therapies. Modulus focuses on engineering immune cell therapies, starting with Natural Killer cells designed for treating solid tumors. The Convergent Design™ platform combines genetic engineering, machine learning, and high-throughput in vivo screening to systematically converge on optimized cell designs. Modulus is committed to discovering cell therapies for a broad set of patient populations not currently served by existing treatments.